Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation
Although the number of clinical applications for fluorine-18 fluorodeoxyglucose (18F-FDG) cardiac positron emission tomography (PET) has continued to grow, there remains a lack of consensus regarding the ideal method of suppressing normal myocardial glucose utilization for image optimization. This review describes various patient preparation protocols that have been used as well as the success rates achieved in different studies. Collectively, the available literature supports using a high-fat, no-carbohydrate diet for at least two meals with a fast of 4-12 hours prior to 18F-FDG PET imaging and suggests that isolated fasting for less than 12 hours and supplementation with food or drink just prior to imaging should be avoided. Each institution should adopt a protocol and continuously monitor its effectiveness with a goal to achieve adequate myocardial suppression in greater than 80% of patients.
KeywordsPET imaging fluorodeoxyglucose (FDG) metabolism inflammation
Positron emission tomography
Dr Murthy owns stock in General Electric, Cardinal Health and Mallinckrodt. Drs Osborne, Hulten, Skali, Taqueti, Dorbala, DiCarli and Blankstein have no disclosures or conflicts of interest related to this publication. The opinions and assertions contained herein are the authors’ alone and do not represent the views of the Walter Reed National Military Medical Center, the US Army, or the Department of Defense.
- 3.Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: Increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374–82.CrossRefPubMedGoogle Scholar
- 4.Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;21:166–74.Google Scholar
- 6.Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244–52.CrossRefPubMedGoogle Scholar
- 8.Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563–8.CrossRefPubMedGoogle Scholar
- 15.Garfein O. Current concepts in cardiovascular physiology. Burlington: Elsevier Science; 2012. p. 565.Google Scholar
- 29.Japanese Society of Sarcoidosis and Other Granulomatous Disorders. Diagnostic standard and guideline for sarcoidosis. Tokyo: Japanese Ministry of Health, Labour and Welfare; 2006. p. 6.Google Scholar